Scientists find a way to ‘fingerprint’ the structure of a monoclonal antibody
Stephanie Sutton |
Precisely measuring the structural configuration of monoclonal antibodies (mAbs) is important when it comes to safety and efficacy. To that end, Robert Brinson, a chemist at the National Institute of Standards and Technology (NIST), and his team have used a technique called near-magnetic resonance (NMR) spectroscopy to measure the fingerprint of mAbs (1). Brinson explains NMR fingerprinting in more detail.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.